Commentary: Management Strategies for POSEIDON Groups 3 and 4
Front Endocrinol (Lausanne)
.
2020 Jan 24:10:920.
doi: 10.3389/fendo.2019.00920.
eCollection 2019.
Author
Klaus F Bühler
1
Affiliation
1
Department of Gynaecology, University Hospital Jena, Jena, Germany.
PMID:
32038485
PMCID:
PMC6992565
DOI:
10.3389/fendo.2019.00920
No abstract available
Keywords:
GnRH analog; POR; POSEIDON IV; Rec-FSH; adjuvants; classification; gonadotrophins; rec-LH.
Publication types
Comment